MedTrace Logo

Natural Cycle or Stimulated Cycle Versus Hormone Replaced Cycle for Pre-eclampsia Rate

NCT04310683 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 840

Last updated 2020-03-17

No results posted yet for this study

Summary

Recent sutdies indicate that the existence of corpus lutein in the ovary is a key point to prevent preeclampsia, and patients undergoing FET with hormone replaced cycle have no corpus lutein and the absence of corpus lutein significantly increases the risk of preeclampsia in these patients. We aim to conduct a single center randomized trial study to compare the preeclampsia rate between the natural cycle and the hormone replaced cycle in patients undergoing FET.

Conditions

  • Pre-Eclampsia

Interventions

OTHER

natural cycle for endometrium preparation

patients will not use oral contraceptive drugs

OTHER

hormone replaced cycle for endometrium preparation

patients will receive oral contraceptive drugs for menstruation before embryo transfer

Sponsors & Collaborators

  • Women's Hospital School Of Medicine Zhejiang University

    lead OTHER

Principal Investigators

  • Dan Zhang, M.D. Ph.D. · Women's Hospital School Of Medicine Zhejiang University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-10
Primary Completion
2021-12-10
Completion
2022-03-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04310683 on ClinicalTrials.gov